Viral vector integrity analysis – Advancements in gene therapy development
Gene therapy offers significant potential for addressing various genetic disorders. Over 30 gene therapies have received FDA approval, with more...
How CAR T Manufacturing is Revolutionizing Cancer Treatment
Chimeric antigen receptor T-cell (CAR T) therapy has emerged as a groundbreaking approach to cancer treatment, particularly for patients with...
Transparent Collaboration in Cell and Gene Therapy Outsourcing: Pioneering Efficiency and Innovation
In cell and gene therapy (CGT) development and manufacturing, the quest for efficiency and innovation is unceasing.
Scaling Up Gene Therapy Manufacturing: Strategies to Overcome Capacity Challenges
As vector-delivered advanced therapies inch towards commercialization, a significant bottleneck has emerged: experienced manufacturing capacity.
Developing Cell and Gene Therapies with a CDMO
Developing cell and gene therapies (CGTs) is a complex and highly specialized process that often requires collaboration with various experts and organizations.
Fast-Tracking Cancer Therapy Advancements: The Triad of Platform, Process, and Partnership
The landscape of cancer therapy is evolving at an unprecedented pace, with breakthroughs in research and technology paving the way for innovative treatments.
Plasmid Power: Navigating Challenges with Precision and Quality in Advanced Therapy Development
When developing advanced therapies, the significance of plasmids cannot be overstated. These genetic building blocks form the backbone of cell and gene therapies
The Future of Advanced Therapy Delivery: Insights from Industry Experts
The realm of advanced therapies is on the cusp of an evolution, driven by the need to overcome the challenges that come with the success…
Navigating Preclinical Manufacturing: Paving the Path to Clinical Success
Cell and gene therapy has tremendous potential, yet the journey from discovery to clinical success is a multifaceted endeavor.